🔴 Intravenous Infusions is trading 3.95% down today amid unexplained stock-specific pressure

Intravenous Infusions is trading at GHS 0.73, with a -3.95% change now amid unexplained, stock-specific trading pressure.

• No credible company-specific announcement dated September 3, 2026 was identified.
• Recent coverage instead concerns earlier financing, ownership changes, and first-half profitability.
• Healthcare-sector strength does not explain this contrary-direction decline; available evidence points to unexplained stock-specific pressure rather than a confirmed catalyst.